Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx [Phase 3]
Phase 3 trial evaluating radiation therapy with or without chemotherapy for advanced laryngeal cancer; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery [Phase 3]
Phase 3 clinical trial update evaluating radiation therapy with or without chemotherapy for head and neck cancer that has been surgically re…
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 3]
Phase 3 clinical trial update on fractionated radiation therapy for advanced squamous cell carcinoma of the head and neck; the study status …
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer [Phase 2]
Phase 2 trial of adjuvant cetuximab with chemoradiation in head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial update of induction therapy with paclitaxel, carboplatin, and radiotherapy for locally advanced head and neck squamous cell ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck [Phase 2]
This Clinical Trial Update reports the completion of a Phase 2 study evaluating chemoradiotherapy for intermediate-stage and selected Stage …
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck [Phase 1]
A completed Phase 1 study assessing the safety and tolerability of AG013 in oral mucositis in patients receiving induction chemotherapy for …
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx [Phase 2]
This clinical trial update reports on a Phase 2 study evaluating the combination of chemotherapy and radiation therapy in patients with prev…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer [Phase 2]
A Phase 2 clinical trial evaluating rosiglitazone for locoregionally extensive or metastatic thyroid cancer is described. The sponsor is Uni…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Phase 1, Phase 2]
Clinical trial update reports pharmacokinetic data for zalutumumab in head and neck cancer patients across Phase 1 and Phase 2; study is com…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery [Phase 3]
Phase 3 trial comparing surgery plus radiation versus chemotherapy plus radiation for stage III/IV head and neck cancer that can be removed …
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating the combination of cisplatin and epinephrine in patients with recurr…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer [Phase 2]
Phase 2 clinical trial evaluating a vaccine therapy in combination with celecoxib for metastatic nasopharyngeal carcinoma; this entry provid…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer [Phase 2]
Phase 2 clinical trial evaluating a cisplatin-epinephrine injectable gel in combination with paclitaxel and carboplatin for recurrent head a…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
The document reports the termination of a Phase 2 trial evaluating oxaliplatin with 5-fluorouracil in patients with recurrent or metastatic …
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: BNCT and IG-IMRT for Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating boron neutron capture therapy combined with image-guided IMRT for recurrent head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer [Phase 1, Phase 2]
This clinical trial update discusses a phase 1/2 study of amifostine in combination with chemotherapy and radiation therapy for patients wit…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial evaluating a gene therapy for patients with recurrent head and neck cancer. The current status of the trial is unkn…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating the combination of erlotinib and docetaxel in patients with locally advanced, metastatic, or recur…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer [Phase 3]
A Phase 3 trial evaluated sargramostim (Leukine) to reduce oral mucositis in patients undergoing radiation therapy for head and neck cancer;…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer [Phase 2]
Phase 2 study evaluating sargramostim to prevent mucositis in patients receiving radiation therapy for laryngeal cancer. The trial has compl…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Lapatinib and Cetuximab in Patients With Solid Tumors [Phase 1]
A Phase 1 clinical trial update reports completion of a study evaluating lapatinib and cetuximab in patients with solid tumors, including co…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract [Phase 2]
A Phase 2 trial evaluating photodynamic therapy with porfimer sodium for aerodigestive tract precancerous lesions and head and neck cancer h…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer [Phase 1]
Phase 1 trial of cediranib (AZD2171) in patients with non-small cell lung cancer and head and neck cancer has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors [Phase 2]
Phase 2 study of BI-2536 in patients with recurrent or metastatic solid tumors, including breast cancer, endometrial cancer, head and neck c…